Molecular Templates Announces Debt Payoff and Restructuring
Restructuring agreement with K2 HealthVentures (K2HV) to fully discharge and satisfy outstanding debt owed to K2HV for the prepayment of…
Pharmaceuticals, Biotechnology and Life Sciences
Restructuring agreement with K2 HealthVentures (K2HV) to fully discharge and satisfy outstanding debt owed to K2HV for the prepayment of…
The Company Vended its Debt and Equity Interest in Propagation Services Canada Inc. for an aggregate of $250,000 and Nick…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of…
YARDLEY, Pa., June 16, 2023 (GLOBE NEWSWIRE) — OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear,…
78% Overall Response Rate (14/18 patients), including seven patients exhibiting a complete response to TT11X allogeneic CAR-T therapySafety data encouraging…
— Publication shows FRESCO-2 demonstrated treatment with fruquintinib reduced the risk of death by 34% in previously treated metastatic colorectal…
– Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE…
Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12,…
Salipro Japan Patent Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan Salipro Biotech obtains granted patent…